SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

Completed · Not applicable · Has a placebo group

Conditions studied: Hypertension, Vascular Diseases, Cardiovascular Diseases

In brief

The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications.

Key facts

Study ID
NCT02439775
Run by
Medtronic Vascular
People needed
337
Starts
2015-07-22
Expected to finish
2025-08-14
Last updated by the study team
2026-07-30

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.